-
Published02/07/2024
-
Deadline31/07/2024
-
Opening of tenders31/07/2024
-
Today07/10/2026
Utilities
- indicates text translated automatically in your browsing language
Framework agreement for the supply of Ranibizumab
This contract concerns a public supply contract for a framework agreement for the purchase of Intravitreale injection from Ranibizumab. It concerns an agreement for the duration of 2 years, which can be extended a maximum of 2 times for the duration of 1 year each. The extension shall be tacit. The contract can be terminated by the contracting authority provided that a notice period of 3 months is respected. The "technical specifications" can be found under section "III. Technical specifications".
https://www.publicprocurement.be
https://www.publicprocurement.be
Type: cost
Description: PRIJS (TOTAALBEDRAG VAN DE INVENTARIS)
Weight (percentage, exact): 65
Criterion:
Type: quality
Description: PRODUCTGERELATEERDE CRITERIA
Weight (percentage, exact): 10
Criterion:
Type: quality
Description: ASPECTEN MBT LEVERING, LEVERINGSBETROUWBAARHEID, TRACEERBAARHEID EN SERVICE
Weight (percentage, exact): 25
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.